US 11020492
Gene correction of SCID-related genes in hematopoietic stem and progenitor cells
granted A61KA61K2035/124A61K31/7088
Quick answer
US patent 11020492 (Gene correction of SCID-related genes in hematopoietic stem and progenitor cells) held by Sangamo Therapeutics, Inc. expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2035/124, A61K31/7088, A61K35/545, A61K48/00